Home › Urothelial (Transitional Cell) Carcinoma › Texas › The Woodlands
Urothelial (Transitional Cell) Carcinoma clinical trials in The Woodlands, TX
5 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
RecruitingPhase 3
- Houston Methodist The Woodlands Hospital, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 11 mi away
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- Texas Oncology - Gulf Coast, The Woodlands
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- US Oncology Research Network, The Woodlands
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
RecruitingPhase 3
- Renovatio Clinical - The Woodlands Research Center, The Woodlands
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in The Woodlands
- Non-Small Cell Lung Cancer15 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Macular Degeneration9 studies
- Cardiovascular Disease9 studies
- Metastatic Cancer9 studies
- Type 2 Diabetes7 studies
- Heart Failure7 studies
- Lung Cancer7 studies
- Atherosclerosis6 studies
- Geographic Atrophy6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.